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Chakalaka-induced vasodilatation in patients with chronic 
myeloid leukaemia on tyrosine kinase inhibitors 
Marius J Coetzee, Vernon J Louw, Kevin Gartrell, Chris D Viljoen
The tyrosine kinase inhibitors (TKIs) are a new group of drugs 
providing targeted therapy for chronic myeloid leukaemia 
(CML). They vastly increase survival, but compliance is an 
issue because they cause vasodilatation as a side-effect. In 
our experience spices, especially the African sauce or relish 
chakalaka (that contains garlic and chilli), may aggravate the 
vasodilatation induced by TKIs. These spices produce serious 
oedema and headaches. We have found that stopping the 
intake of spice allows some patients to maintain therapeutic 
doses of TKIs. This has been confirmed and put into practice 
by a growing number of South African haematologists. 
As spice that contains chilli and garlic is used by a large 
proportion of our South African (and the world) population, 
this observation is significant in that it can help to prevent 
the ‘compliance decay’ associated with TKI therapy, which 
adversely affects patient survival.
CML represents up to 20% of all leukaemias, with a 
worldwide incidence of about 1 - 2/100 000 per year. There 
may be up to 450 new cases annually in South Africa. Imatinib 
is a tyrosine kinase receptor antagonist that inhibits the 
mutated tyrosine kinases such as Bcr-Abl, c-kit, and platelet-
derived growth factor receptor (PDGFR) in some malignancies. 
It has revolutionised the treatment of Philadelphia 
chromosome-positive CML.
Imatinib causes fluid retention in 7 - 81% of patients.1 Facial, 
peri-orbital and peripheral oedema occur most frequently. 
It causes headache in 27 - 39% of cases,1 and even cerebral 
oedema.2 Pietras et al.3 have proposed that a second, still 
elusive, trigger is needed for these rare effects to occur. 
Dasatinib, another TKI, is a potent PDGFR inhibitor that causes 
fluid retention in up to 50% of patients.4
Compliance with imatinib is vital to prevent relapse, 
so factors that may cause adverse reactions and diminish 
compliance need to be excluded. We report 4 cases of chronic-
phase CML treated with TKIs, in which worsening adverse 
reactions were associated with the use of chillies and garlic.
Case reports
A 36-year-old man had quickly achieved complete 
haematological remission of CML on imatinib 400 mg/d. Three 
months later he developed severe headache and pedal oedema 
hours after eating tinned chakalaka. Apart from very mild 
mitral incompetence controlled with diuretics, there was no 
other likely cause for the oedema. The oedema subsided, but 
was still present when we saw him 2 days later. It disappeared 
within 4 days, without adjustment of the imatinib dose. After 
this he avoided chakalaka and spices, and the oedema did not 
recur.
Subsequently, 3 more patients on TKIs experienced adverse 
reactions probably related to consuming garlic and chillies, two 
main ingredients of chakalaka.
The second patient was a 70-year-old man with Philadelphia 
chromosome-positive CML. He had hypertension, which was 
controlled well with nifedipine and perindopril. Three weeks 
after starting imatinib 400 mg/d he developed oedema, rash 
and headaches. He continued at the same dose, but after 
several months had not achieved haematological remission. 
The imatinib dose was increased to 600 mg/d, and the 
headaches intensified. There were no abnormal neurological 
findings. The symptoms subsided within 10 days after he 
avoided chillies and garlic. He later achieved a complete 
cytogenetic remission without further adverse effects.
The third patient was a 20-year-old woman with 
Philadelphia chromosome-positive CML who could not 
tolerate imatinib 400 mg daily because of intractable oedema, 
headaches, and nausea. She took no other medication and was 
normotensive. Because of the adverse effects and progressive 
disease, she was switched to dasatinib 140 mg daily. The 
oedema and nausea disappeared, but she immediately 
developed incapacitating headaches, without hypertension 
or neurological signs. These disappeared within 10 days 
after she avoided chillies and garlic, without adjusting the 
dasatinib dose. After she ate a spicy meal a few weeks later the 
headaches recurred briefly. Unfortunately, after 4 months she 
had not achieved an adequate response and was prepared for a 
stem cell transplant.
The fourth patient was a 28-year-old man with Philadelphia 
chromosome-positive CML who was started on dasatinib 100 
mg daily. He developed a swollen leg and a severe headache 
12 hours after eating food spiced with a lot of curry powder 
that contained chillies. The symptoms had all but disappeared 
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by the time we saw him 60 hours after the meal. He refused 
to have a deep-vein thrombosis excluded. His recurrent 
headaches improved when he avoided spices. He was found to 
have the CYP3A4*1G allele, single-nucleotide polymorphism, 
of the CYP3A4 variant of P450,5 which has however not been 
demonstrated to slow TKI metabolism.
Discussion
Imatinib may cause vasodilatation and fluid retention due 
to inhibition of the PDGFR kinase that regulates interstitial 
fluid pressure. PDGFβ- and PDGFRβ-knockout mice exhibit 
haemorrhages and oedema.3
We propose a possible second trigger for adverse effects 
related to fluid retention, namely garlic and chillies. These 
are found in chakalaka (isiZulu for ‘chilli and tomato dish’), 
a popular traditional spicy relish. It contains chilli, garlic, 
tomatoes, green chilli peppers, grated carrots and cabbage, 
with beans or diced cauliflower. It is mostly home-made, but 
also available as a genetically modified organism-free canned 
product.
Chillies (Capsicum annuum) contain the strongly vasodilatory 
capsaicin. Capsaicin binds to the TRPV1 channel (transient 
receptor potential channel A1 or vanilloid receptor 1) (Fig. 
1), which stimulates capsaicin-sensitive primary efferent 
neurons that project to cardiovascular and renal tissues.6,7 This 
causes secretion of stored neurotransmitters, calcitonin gene-
related peptide (CGRP) and substance P, which are potent 
vasodilators.7
Garlic contains the pungent organosulphur compounds 
allicin and diallyl disulphide (DADS). Allicin and DADS 
induce inflammation and pain by activating TRPA1, an 
excitatory ion channel on primary sensory neurons in the 
pain pathway.8 These are the same neurons that respond to 
capsaicin. The vasorelaxation induced by DADS and allicin 
is probably mediated by the release of calcitonin gene-related 
peptide (CGRP) from capsaicin-sensitive nerve terminals.8 
Garlic also contains ajoene, a potent vasorelaxant.
The clinical improvement seen after withdrawal of 
the above substances would support the role of one or 
more of these compounds in side-effects related to fluid 
retention.  Pharmacokinetic interactions that may have led 
to increased doses of the TKIs cannot be excluded. Some 
complementary and alternative medicines (CAMs) influence 
imatinib pharmacokinetics. St John’s wort, garlic, kava-kava, 
ginseng and rapeseed extract decrease imatinib plasma 
levels by inducing CYP3A4.  Further studies, including the 
determination of plasma levels of TKIs during exposure to 
herbal compounds, may elucidate the reactions we observed.
About 25% of the world’s population eats hot chillies daily.5 
It is highly probable that interaction may occur between these 
and TKIs. Fluid retention may require reduction of the imatinib 
dose, with reduced therapeutic effect. It is therefore important 
to ask about intake of spice and garlic when a patient on TKIs 
presents with oedema or headaches. Most patients using CAMs 
together with their oncotherapeutic drugs do not tell their 
doctor, so it is advisable to ask about these too. Further studies 
are needed to examine the interplay between TKIs and food 
substances.
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Fig. 1. The proposed mechanism of vasodilatation after exposure of a 
vanilloid-sensitive nerve ending to capsaicin or garlic and TKIs. Capsaicin 
binds to the vanilloid receptors TRPA1 (transient receptor potential 
channel A1). DADS (allicin and diallyl disulphide), allicin and AITC 
(allyl isothiocyanate) all bind the TRPA1 (transient receptor potential 
A1) channel. Both stimulate substance P (SP) and calcitonin gene-related 
peptide (CGRP), which cause vasodilation. Stimulated mast cells release 
histamine, which also contributes to vasodilatation. TKIs contribute to va-
sodilatation by inhibiting PDGFR (platelet-derived growth factor receptor) 
kinases. (After Szallasi and Blumberg.7)
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